Study explores adverse effects associated with psychotherapy

Psychotherapy is a key evidence-based method of treatment and rehabilitation for various mental health disorders, in addition to pharmacotherapy.

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575 million, lowering hopes of a buyout

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech

May 22, 2024

New device rapidly provides white blood cell count with a single drop of blood

A Rutgers researcher, through his spinoff company, has led a team to design and test a device that quickly counts a person’s white blood cells

January 19, 2024

Management Board of M1 Kliniken AG acquires 1.5 million shares in the company and plans an uplisting to the Prime Standard – Biotech Investments

EQS-News: M1 Kliniken AG / Key word(s): Investment Management Board of M1 Kliniken AG acquires 1.5 million shares in the company and plans an uplisting

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.